Man Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-900
Closed -$365K 2468
2025
Q2
$365K Sell
900
-12,100
-93% -$5.06M ﹤0.01% 1923
2025
Q1
$6.47M Sell
13,000
-16,200
-55% -$8.77M 0.02% 912
2024
Q4
$15.2M Buy
29,200
+14,900
+104% +$8.19M 0.04% 551
2024
Q3
$8.85M Buy
14,300
+4,700
+49% +$2.78M 0.02% 802
2024
Q2
$5.31M Buy
9,600
+6,800
+243% +$3.9M 0.01% 984
2024
Q1
$1.63M Sell
2,800
-1,500
-35% -$842K ﹤0.01% 1384
2023
Q4
$2.28M Buy
+4,300
New +$2.08M 0.01% 1238

Other funds holding TMO

Man Group's TMO Position: Q1 2026 in Review

Man Group increased its Thermo Fisher Scientific (TMO) stake by 176% in Q1 2026, buying an estimated $16.1M and bringing the position to 46,402 shares worth $22.8M. The position accounts for 0.04% of the portfolio, ranked #443.

Man Group first reported a position in TMO in Q1 2018 and has held it in 30 quarters since. The position peaked at $132M in Q3 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Man Group held 46,402 shares of Thermo Fisher Scientific worth $22.8M as of Q1 2026.
  • Man Group bought 29,581 Thermo Fisher Scientific shares in Q1 2026, an estimated $16.1M.
  • Thermo Fisher Scientific made up 0.04% of Man Group's portfolio in Q1 2026, its #443 holding.
  • Man Group first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 30 quarters since.
  • Man Group's Thermo Fisher Scientific position peaked at $132M in Q3 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.